USPTO serial 50182138
NEUBENVI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with NEUBENVI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly Bullock Gatling
Kimberly Bullock Gatling Fox Rothschild LLP212 Carnegie Center Drive, Suite 400Princeton, NJ 08540United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of mental health disorders, including neurological conditions and psychiatric conditions;; Pharmaceutical preparations for the treatment of mental health disorders, including depression and anxiety | ACTIVE | — |
| 042 | Pharmaceutical drug development services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 26, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2026 | NWAP | NEW APPLICATION ENTERED | — |